Airway Cash Flow Conversion Efficiency
Airway cash flow conversion efficiency. Based on the latest financial reports, Airway (AWM) has a cash flow conversion efficiency ratio of -0.055x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł469.00K ≈ $129.08K USD) by net assets (zł-8.50 Million ≈ $-2.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Airway (2014–2025)
Cash flow conversion efficiency of Airway from 2014 to 2025. This chart illustrates how Airway's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Airway share price for real-time trading data and today's change.
Airway Cash Flow Conversion Ratio Explained
Airway cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Airway Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Airway ranked by their cash flow conversion efficiency. Also see AWM company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Muza S.A
WAR:MZA
|
0.068x |
|
Nuchev Ltd
AU:NUC
|
-0.107x |
|
Lykos Metals Ltd
AU:LYK
|
-0.312x |
|
Samyang Corp Preference Shares
KO:145995
|
-0.026x |
|
Turbon AG
F:TUR
|
0.056x |
|
Jenn Feng New Energy Co Ltd
TW:1538
|
-0.072x |
|
KWESST MICRO SYS.INC.
F:62UA
|
-0.430x |
|
Soligenix Inc.
NASDAQ:SNGX
|
-0.257x |
Annual Cash Flow Conversion Efficiency for Airway (2014–2025)
The table below shows the annual cash flow conversion efficiency of Airway from 2014 to 2025. Review AWM cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | zł-8.50 Million ≈ $-2.34 Million |
zł-3.38 Million ≈ $-930.78K |
0.398x | +27.50% |
| 2024-12-31 | zł-24.32 Million ≈ $-6.69 Million |
zł-7.59 Million ≈ $-2.09 Million |
0.312x | -1.74% |
| 2023-12-31 | zł-13.21 Million ≈ $-3.63 Million |
zł-4.20 Million ≈ $-1.15 Million |
0.318x | +859.23% |
| 2022-12-31 | zł-13.35 Million ≈ $-3.67 Million |
zł-442.00K ≈ $-121.64K |
0.033x | +113.52% |
| 2021-12-31 | zł23.90 Million ≈ $6.58 Million |
zł-5.85 Million ≈ $-1.61 Million |
-0.245x | -233.92% |
| 2020-12-31 | zł30.65 Million ≈ $8.44 Million |
zł-2.25 Million ≈ $-618.68K |
-0.073x | -148.32% |
| 2019-12-31 | zł32.83 Million ≈ $9.04 Million |
zł4.98 Million ≈ $1.37 Million |
0.152x | +265.97% |
| 2018-12-31 | zł34.01 Million ≈ $9.36 Million |
zł-3.11 Million ≈ $-855.92K |
-0.091x | +37.36% |
| 2017-12-31 | zł25.25 Million ≈ $6.95 Million |
zł-3.69 Million ≈ $-1.01 Million |
-0.146x | -17.16% |
| 2016-12-31 | zł24.29 Million ≈ $6.69 Million |
zł-3.03 Million ≈ $-833.07K |
-0.125x | -89.16% |
| 2015-12-31 | zł15.15 Million ≈ $4.17 Million |
zł-998.00K ≈ $-274.66K |
-0.066x | -45.77% |
| 2014-12-31 | zł44.41 Million ≈ $12.22 Million |
zł-2.01 Million ≈ $-552.36K |
-0.045x | -- |
About Airway
Airway Medix S.A. engages in the research, development, and commercialization of medical devices for the mechanically ventilated patients in the intensive care units and for the patients in life-threatening conditions in the anaesthesiology departments in Poland and internationally. It offers Closed Suction System, a dual operation of balloon swiping and suction; B-Oral Care for intubated hospita… Read more